Simon Mølgaard Named Rising Star in Danish Biotech

We are proud to congratulate Simon Mølgaard, CEO of our portfolio company Teitur Trophics, on being awarded the Rising Star in Danish Biotech at the Biotech Spring Gala — with the recognition displayed on Nasdaq’s iconic screen in Times Square, New York.

This is a testament to Simon’s leadership and the exciting trajectory of Teitur Trophics. We look forward to continuing to support the company on its journey.

Latest news

Theolytics

Theolytics Relocates to State-of-the-Art Facility at ARC Oxford to Drive Development of THEO-260 and Other Novel Oncolytic Immunotherapies

2026.07.162026.07.16 / Oxford UK, July 14th, 2026. Theolytics, a clinical-stage biotechnology company developing next-generation oncolytic immunotherapies, announces that it has relocated to new, state-of-the-art facilitie ...

Simon Mølgaard Named Rising Star in Danish Biotech

2026.06.292026.06.29 / We are proud to congratulate Simon Mølgaard, CEO of our portfolio company Teitur Trophics, on being awarded the Rising Star in Danish Biotech at the Biotech Spring Gala — with the recognition display ...

AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet

2026.06.252026.06.29 / Favourable safety profile in marked contrast to traditional inotropic therapeutics AC01 showed rapid and sustained improvements in cardiac output, structure and function STOCKHOLM, Sweden, [D ...